U.K.-based Newton's Tree has unveiled its Global AI Evaluation Service, a network available in Europe and the U.S. that offers validation for AI healthcare products.
The service provides technical validation, performance testing, and budget impact analyses that "help AI vendors accelerate market entry and adoption," the company said.
The vendor listed the following initial participants in the service:
- German Medical Institute in Cyprus
- Great Ormond Street Hospital for Children, in London
- Leeds Teaching Hospitals NHS Trust, U.K.
- National Health Service (NHS) Greater Glasgow and Clyde in Scotland
- Tanner Health in the U.S.
For more details, go to the RSNA website.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
